The University of Alabama’s newest cancer-killing cyclotron was installed
On Mar. 5, 2019, Emma, the 90-ton cyclotron which is the centerpiece of the new proton therapy initiative…
On Mar. 5, 2019, Emma, the 90-ton cyclotron which is the centerpiece of the new proton therapy initiative…
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…
On Jan. 18, 2019 Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
On Dec. 15, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
On Nov. 29, 2018, St. Louis native Rodger Riney and his wife, Paula, donated $20 million to research…
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 22, 2018, the National Cancer Institute awarded a $10.7 million five year grant to Abramson Cancer…
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
On Sept. 27, 2018, St.ï¾ Jude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
On Sept. 7, 2018, Oregon Health & Science University (OHSU) announced the official completion of the Knight Cancer…
On Aug. 29, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it would invest up…
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
On Aug. 2, 2018, Emory University and GeoVax Labs partnered to develop a vaccine for HPV, with an…
On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…
On Jun. 5, 2018, a new flagship cancer center was established as the Fred & Pamela Buffett Cancer…
On Jun. 3, 2018, findings were reported from the groundbreaking Trial Assigning Individualized Options for Treatment (Rx), or…
On May 31, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a new Early Translational…
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…